ARCHIVES

FDA Proposes New User Fees for Generics and Biosimilar Products

This article is from The Cancer Letter archive.

Vol. 38 No. 03 | January 20, 2012

Download PDF Visit The Full Archive

Related Articles

ACCP and ASCO Publish Joint Guideline Following Review of Evidence on Low-Dose CT

May 25, 2012

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

Program Announcement On Effects Of Low Dose Radiation

October 2, 1981

Nixon Tells ACCC U.S., USSR Should Be Allies In War Against Cancer

April 11, 1986

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997